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a  b  s  t  r  a  c  t
Vibrio  cholerae  and  enterotoxic  Escherichia  coli  (ETEC)  remain  two  dominant  bacterial  causes  of  severe
secretory  diarrhea  and  still a  signiﬁcant  cause  of death,  especially  in  developing  countries.  In order  to
investigate  new  effective  and  inexpensive  therapeutic  approaches,  we  analyzed  nanoparticles  synthe-
sized  by  a green  approach  using  corresponding  salt  (silver  or zinc  nitrate)  with  aqueous  extract  of  Caltropis
procera  fruit  or leaves.  We  characterized  the  quantity  and  quality  of  nanoparticles  by UV–visible  wave-
length  scans  and  nanoparticle  tracking  analysis.  Nanoparticles  could  be  synthesized  in reproducible  yields
of approximately  108 particles/ml  with  mode  particles  sizes  of approx.  90–100  nm.  Antibacterial  activity
against  two pathogens  was assessed  by  minimal  inhibitory  concentration  assays  and  survival  curves.  Both
pathogens  exhibited  similar  resistance  proﬁles  with  minimal  inhibitory  concentrations  ranging  between
5  × 105 and  107 particles/ml.  Interestingly,  zinc  nanoparticles  showed  a slightly  higher  efﬁcacy,  but sub-
lethal  concentrations  caused  adverse  effects  and  resulted  in increased  bioﬁlm  formation  of  V. cholerae.inimal inhibitory concentration
urvival curve
herapeutic agent
ntimicrobial activity
Using  the  expression  levels  of  the outer  membrane  porin  OmpT  as  an indicator  for  cAMP  levels,  our  results
suggest  that  zinc  nanoparticles  inhibit  adenylyl  cyclase  activity.  This  consequently  deceases  the  levels
of  this  second  messenger,  which  is  a known  inhibitor  of  bioﬁlm  formation.  Finally,  we  demonstrated
that  a single  oral  administration  of  silver  nanoparticles  to  infant  mice  colonized  with  V. cholerae  or  ETEC
signiﬁcantly  reduces  the colonization  rates  of the  pathogens  by  75-  or  100-fold,  respectively.
© 2014  The  Authors.  Published  by Elsevier  GmbH.  This  is an  open  access  article  under  the  CC  BYntroduction
Recently, nanotechnology has become increasingly important
n the biomedical and pharmaceutical areas as alternative antimi-
robial strategy due to re-emergence infectious diseases and the
ppearance of antibiotic-resistant strains especially within Gram-
egative microorganisms (Desselberger, 2000). Biosynthesis of
reen nanoparticles using plant extracts is an interesting area in the
eld of nanotechnology, which has economic and eco-friendly ben-
ﬁts over chemical and physical methods of synthesis (Suzan et al.,
014). Nanoparticles (NPs) are typically no greater than 100 nm
n size and their biocidal effectiveness is suggested to be owing
o a combination of their small size and high surface-to-volume
∗ Corresponding author. Tel.: +43 0316 380 1970; fax: +43 0316 380 9019.
E-mail address: stefan.schild@uni-graz.at (S. Schild).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.ijmm.2014.11.005
438-4221/© 2014 The Authors. Published by Elsevier GmbH. This is an open access articlicense  (http://creativecommons.org/licenses/by/3.0/).
ratio, which enable intimate interactions with microbial mem-
branes (Allaker, 2010; Morones et al., 2005). In addition, inorganic
antibacterial agents such as metal and metal oxides are advanta-
geous compared to organic compound due to their stability (Sawai,
2003; Sondi and Sondi, 2004). Among these metal oxides, ZnO has
attracted a special attention as antibacterial agent. For instance,
ZnO inhibits the adhesion and internalization of enterotoxigenic
E. coli (ETEC) into enterocytes (Roselli et al., 2003). In addition,
ZnO nanoparticles (ZnO-NPs) exhibit antibacterial activity and can
reduce the attachment and viability of microbes on biomedical sur-
faces (Brayner et al., 2006; Yamamoto, 2001). Interestingly, several
results suggest a selective toxicity of ZnO-NPs preferentially tar-
geting prokaryotic systems, although killing of cancer cells has
also been demonstrated (Hanley et al., 2008; Reddy et al., 2007;
Taccola et al., 2011). Several mechanisms have been reported for the
antibacterial activity of ZnO-NPs. For example ZnO-NPs can inter-
act with membrane lipids and disorganize the membrane structure,
which leads to loss of membrane integrity, malfunction, and ﬁnally
le under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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o bacterial death (Krishnamoorthy et al., 2012; Zhang et al., 2007).
nO may  also penetrate into bacterial cells at a nanoscale level
nd result in the production of toxic oxygen radicals, which dam-
ge DNA, cell membranes or cell proteins, and may  ﬁnally lead to
he inhibition of bacterial growth and eventually to bacterial death
Apperlot et al., 2009; Irzh et al., 2010; Makhulf et al., 2005; Moody
nd Hassan, 1982; Zhang et al., 2007).
Furthermore, Ag+ ions and Ag-based compounds are highly toxic
o several microorganisms, which make them interesting candi-
ates for multiple applications in the medical ﬁeld (Furno et al.,
004; Prakash et al., 2013). Ag is generally used as nitrate salt, but in
he form of Ag nanoparticles (Ag-NPs) the surface area is increased
nd thereby antimicrobial efﬁcacy is greatly enhanced. Though Ag-
Ps ﬁnd use in many antibacterial applications, the action of this
etal on microbes is not fully known. It has been hypothesized that
ilver nanoparticles can cause cell lysis or growth inhibition via var-
ous mechanisms (Kim et al., 2007; Prabhu and Poulose, 2012). The
ethality of silver for bacteria can also be in part explained by thiol-
roup reactions that inactivate enzymes (Chen and Schluesener,
008; Feng et al., 2000). Also, Steuber and colleagues suggested
 mechanism for Ag+ action in Vibrio alginolyticus involving the
irect displacement of FAD from the holo-enzyme Na+-NQR, which
esults in loss of enzyme activity (Steuber et al., 1997). In summary,
ilver treatment inhibits DNA replication, expression of ribosomal
nd other cellular proteins, and interferes with the bacterial elec-
ron transport chain (Bragg and Rainnie, 1974; Feng et al., 2000;
amanaka et al., 2005).
Several reports demonstrated the synthesis of ZnO- and Ag-NPs
rom natural sources like plants or microorganisms by green chem-
stry approaches (Babu and Prabu, 2011). The use of plant extracts
or nanoparticles synthesis may  be advantageous over other biolog-
cal processes, because it drops the elaborate process of maintaining
ell cultures and can also be used for large-scale NPs synthesis
Jeeva et al., 2014). Additionally, the green chemistry approach for
he synthesis of NPs using plants avoids the generation of toxic
yproducts. Among the various known synthesis methods, plant
ediated NPs synthesis is preferred as it is cost-effective, eco-
riendly and safe for human therapeutic use (Kumar and Yadav,
009).
Diarrheal diseases are still a common worldwide cause of mor-
idity and mortality especially in the developing world. Within
hese areas, V. cholerae (∼25%) followed by ETEC (∼15%) are
ost prevalent bacterial pathogens causing diarrheal diseases
Chowdhury et al., 2011; Walker et al., 2007). V. cholerae is the
ausative agent of cholera, a life-threatening secretory diarrheal
isease. According to Southeastern and Central Asia reports the
nnual acute diarrheal cases for V. cholerae infection were esti-
ated more than 1 million (WHO, 2013). ETEC is a common cause
f traveler’s diarrhea, being responsible for up to one-half of diar-
heal episodes in travelers to Asia, Africa and Latin America (Gupta
t al., 2008; Qadri et al., 2005; Sanchez and Holmgren, 2005; Tobias
t al., 2011). Particularly children show a high mortality rate in
eveloping countries where diarrheal diseases remain the second
ost common cause of death (Levine, 2006). Even today treatment
f these diarrheal diseases relies on a simple rehydration therapy,
ometimes in combination with antimicrobial agents (Sack et al.,
004). The rehydration therapy is highly effective, but appropriate
terile solutions, antibiotics and medical expertise are not always
vailable and during the explosive outbreaks medical facilities can-
ot cope with the massive numbers of incoming patients. Thus,
lternative strategies should be investigated.
Calotropis procera is a shrub (F: Asclepiadaceae) distributed in
est Africa, Asia and other parts of the tropics. The plant is erect,
all, large, branched and perennial with milky latex throughout
Irvine, 1961). Interestingly, Babu and Prabu recently described the
g-NPs synthesis using aqueous extract of Calotropis procera ﬂower,dical Microbiology 305 (2015) 85–95
while the reduction was considered to occur due to the phenolics,
terpenoids, polysaccharides and ﬂavonoids present in the extract
(Babu and Prabu, 2011).
In the present study, we  synthesized metallic ZnO- and Ag-NPs
using leaf and fruit extract of Calotropis procera and characterized
their antibacterial activity against V. cholerae and ETEC. Espe-
cially Ag-NPs synthesized from leaf extracts showed the most
robust antibacterial efﬁcacy against both pathogens throughout the
study. Furthermore, these Ag-NPs reduced ﬁtness of the bacteria in
bioﬁlms as well as in vivo.
Materials and methods
Bacterial strains, culture conditions and supplements. V.
cholerae AC53 and ETEC H10407, spontaneous streptomycin-
resistant (SmR) derivatives of the clinical isolates O1 El Tor
Ogawa E7946 (Miller et al., 1989); (Schild et al., 2007) or ETEC
O78:H11:K80 (Evans and Evans, 1973), were used in this study.
Unless stated otherwise strains were grown in LB broth with aer-
ation at 37 ◦C or for bioﬁlm formation under static conditions at
room temperature (RT). If required, streptomycin was used with a
ﬁnal concentration of 100 g/ml.
Plant materials and preparation of the extracts
Healthy leaves and fruits of Caltropis procera were collected from
South Valley University campus at Qena city (Egypt), washed thor-
oughly with tap water followed by distilled water, and air dried on
a paper towel for 4–6 days. Dry leaves were shredded and ground
in a tissue grinder (IKA A10, Germany) to ﬁne powder. Ten grams
of the powder were dissolved in 100 ml  sterile double distilled
water and heated for 1 h at 80 ◦C. The obtained extract was ﬁltered
through Rotilabo® Typ 601P ﬁlter paper; the ﬁltrate was collected
in a 250 ml  Erlenmeyer ﬂask and then stored at 4 ◦C for further use
(modiﬁed from (Verastegui et al., 1996).
Green synthesis of silver and zinc oxide nanoparticles (Ag-NPs and
ZnO-NPs)
Ag-NPs and ZnO-NPs were essentially synthesized as previously
described (Babu and Prabu, 2011; Prakash et al., 2013; Sangeetha
et al., 2011, 2012; Sun et al., 2014; Suzan et al., 2014; Vimala et al.,
2014) using leaves (L) or fruits (F) extracts from C. procera result-
ing in the four different types of nanoparticles Ag-NPs-L, Ag-NPs-F,
ZnO-NPs-L and ZnO-NPs-F. Solutions with silver nitrate or zinc
nitrate (without C. procera extract) were also incubated at the same
conditions and served as a negative control (Kumar et al., 2011).
To obtain Ag-NPs, 20 ml  of a 1 mM AgNO3 (Sigma–Aldrich)
solution were added drop-wise to 20 ml  of the respective aque-
ous plant extract of C. procera under constant stirring at 80 ◦C
within 30–45 min, for the reduction of Ag+ ions. This material
was incubated in the dark (to minimize the photoactivation of sil-
ver nitrate) at 37 ◦C. The synthesis of ZnO-NPs was performed as
previously described with some modiﬁcations. Brieﬂy, 2 g of zinc
nitrate (Sigma–Aldrich) was  dissolved in 100 ml aqueous leaf or
fruit extracts solution of C. procera under constant stirring. After
complete dissolution of the mixture, the solution was kept under
vigorous stirring at 80 ◦C for 2 h, subsequently allowed to cool at
room temperature and the supernatant was  discarded. Obtained
NPs solutions were centrifuged at 4,500 rpm for 15 min  after thor-
ough washing and dried at 80 ◦C for 7–8 h. Crude pellets were
then resuspended in sterile double distilled water, ﬁltered through
0.2 m ﬁlter and stored at 4 ◦C in the dark prior to their use.
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V–vis spectrophotometry
The reduction of Ag+ ions or ZnO was assessed by measuring the
V–vis spectrum of 1 ml  aliquots of sample in a cuvette as described
arlier (Wiley et al., 2006). UV–vis spectral analysis for Ag-NPs and
nO-NPs was carried out by measuring the optical density (OD)
sing the SPECTROstarNANO, BMG  labtech, Germany scanning spec-
rophotometer. Measurements were performed between 220 and
,000 nm with a resolution of 1 nm.  Silver nitrate (1 mM)  or zinc
itrate (2%) were used as a blank, respectively.
nductively coupled plasma mass spectrometry (ICP-MS)
Elements were determined in the samples after mineralization
ith nitric acid using ICP-MS. Brieﬂy, the liquid samples (∼500 mg
eighed to 0.1 mg)  were placed in 12 ml  quartz vessels, 1 ml  sub-
oiled nitric acid was added and the samples were placed in the
utoclave (UltraCLAVE IV, EMLS, Leutkirch, Germany). Then the
utoclave was  pressurized with argon to 40 bars and the samples
eated in 45 min  to a temperature of 250 ◦C and kept at this tem-
erature for 45 min. After cooling the samples were transferred into
5 ml  polypropylene tubes (Greiner Bio-One). Zn (determined at
/z 66) and Ag (determined at m/z  107) were determined with ICP-
S (Agilent 7500ce, Agilent Technologies, Waldbronn, Germany)
fter appropriate dilution. The accuracy of the results was  vali-
ated with the certiﬁed reference material 1640a (trace elements
n water, NIST, Gaithersburg, ML,  USA).
anoparticle tracking analysis (NTA) measurements
To determine the size characteristics of the bio-synthesized
anoparticles NTA was performed using the NanoSight LM10 HS-
88FT14 instrument (Malvern Instruments, Herrenberg, Germany).
he nanoparticle solutions were diluted in ﬁlter-sterilized
0.02 mm)  double distilled water and 300 l of each sample was
njected to the viewing unit using a disposable syringe. The con-
entration of the NPs was adjusted to a particle number between
06 and 109 particles per ml.  A laser (wavelength 405 nm)  illumi-
ates the particles from aside, and the particles act as point scatters
oving under Brownian motion. Despite rapid movements of the
articles, they can be tracked by a conventional CCD camera. The
ecorded video can subsequently be analyzed analytically by a soft-
are program (NTA 2.3, Build 0025). The samples were measured
or 60 s with manual shutter and gain adjustments. After capture
f the diffusion coefﬁcient and track lengths for the individual par-
icles a quite accurate determination of the individual particle size
an be made (ASTM, 2012; Patrick et al., 2013). Particle concentra-
ions of the original nanoparticle solutions were calculated by the
easured concentration of the diluted samples multiplied by the
ilution factor.
etermination of the minimum inhibitory concentration (MIC) by
rowth and INT reduction assay
Overnight cultures of V. cholerae or ETEC were subcultured
:10,000 into LB. Samples of 100 l bacterial culture were placed
nto 96-well plates and 10 l of appropriate serial dilutions of Ag-
Ps-L, Ag-NPs-F, ZnO-NPs-L or ZnO-NPs-F were added. At least two
ndependent preparations of each NP type were tested. Leaf or fruit
xtracts alone were also tested and showed no effects compared to
B broth. An additional control consisted of NPs-free supernatants
rom NPs solutions obtained after two consecutive centrifugation
teps (20,000 rpm, 4 h, 4 ◦C). The absence of NPs in the supernatant
as conﬁrmed by NTA. After 16 h incubation in a humid cham-
er at 37 ◦C, the optical density (OD600) was measured using the
pectrostarNANO Microplate Reader (BMG Labtech). The MIC  fordical Microbiology 305 (2015) 85–95 87
growth was  deﬁned as the lowest concentration of NPs, which
inhibited bacterial growth. Growth was  deﬁned by an at least 2-
fold increase of the OD600 compared to the negative control (LB
only). To conﬁrm bacterial growth inhibition and determine lack
of metabolic activity, 40 L of p-iodonitrotetrazolium violet INT
(0.2 mg/mL, Sigma–Aldrich) was added to microplate wells and
reincubated at 37 ◦C for 30 min  (Eloff, 1998). The MIC  in the INT
assay was deﬁned as the lowest concentration of NPs that pre-
vented color change as described earlier (Namrita et al., 2013).
Growth kinetics and viability
Growth kinetics were essentially performed as previously
described in transparent 24-well plates (Greiner) with 1 ml  culture
volume using LB broth, LB broth supplemented with leaf extract
(10%) or LB broth supplemented with fruit extract (10%) starting
at an OD600 = 0.01 (Moisi et al., 2013; Seper et al., 2011). These
ﬁnal concentrations of the plant extracts are at least 2-fold higher
than the respective MIC  of plant extracts with NPs. The OD600 was
monitored every 30 min  in the SPECTROstarNano microplate reader
(BMG Labtech) at 37 ◦C with shaking. For presentation of data, at
least six independent growth curves were monitored for each strain
tested. The mean values were calculated and plotted. At 24 h via-
bility in presence and absence of plant extracts was determined
by plating appropriate dilutions of the cultures on LB plates. The
obtained CFU/ml from at least three independent measurements
are presented as mean ± standard deviation.
Static bioﬁlm assay
Static bioﬁlms were performed in microtiter plates by crystal
violet staining essentially as previously published (Seper et al.,
2011), with some modiﬁcations. Brieﬂy, the respective strains were
grown over night on LB agar plates, suspended in LB, adjusted
to an OD600 of 0.02. 130 l of this dilution were placed in a 96
well microtiter plate (U bottom, Sterilin) for 24 h at RT. After
24 h, 20 l of Ag-NPs-L, Ag-NPs-F, ZnO-NPs-L or ZnO-NPs-F solu-
tions with concentrations of ∼ 108 NPs/ml were added. Addition
of 20 l of LB broth, the plant leaf or fruit extracts from C. pro-
cera served as control. After another 24 h incubation at RT, wells
were subsequently rinsed with dH2O using a microplate washer
(Anthos Mikrosysteme GmbH, Fluido2), bioﬁlm was  stained with
0.1% crystal violet, solubilized in 96% ethanol and the OD595 was
measured (SPECTROstarNANO, BMG  Labtech) to quantify the amount
of bioﬁlm.
Preparation of outer membrane proteins (OMPs) and whole-cell
lysates (WCL)
OMPs were essentially prepared as previously published (Roier
et al., 2013). Brieﬂy, ON cultures of V. cholerae or ETEC grown in
LB with or without sublethal concentrations of Ag-NPs-L or Ag-
NPs-F (both 1 × 106 NPs/ml) as well as ZnO-NPs-L or ZnO-NPs-F
(both 1 × 105 NPs/ml) respectively, as well as 0.025 mM of AgNO3
or 0.1 mM of Zn(NO3)2 solution were harvested by centrifugation
(3,200 × g, 10 min, 4 ◦C), washed once in HEPES buffer (10 mM,
pH 7.4) and resuspended in 1 ml  HEPES buffer (10 mM,  pH 7.4).
Then the suspension was transferred in a cryo-tube and cells were
disrupted by homogenization with 0.1 mm glass beads in combina-
tion with a PowerLyzerTM 24 (MO  BIO Laboratories, Inc.), applying
three times, 1 min  cycles at 3400 rpm with 1 min  intervals on ice
between each cycle. Unbroken cells were removed by centrifuga-
tion (15,600 × g, 2 min, 4 ◦C). The supernatant containing the OMPs
was transferred into a new tube and centrifuged again (15,600 × g,
30 min, 4 ◦C). The membrane pellet was re-suspended in 0.4 ml
HEPES buffer (10 mM,  pH 7.4). To solubilize the cytoplasmic
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yield or quality, suggesting a reproducible production of the NPs.
In general, all NP preparations showed similar results with mean
concentrations ranging from 1.65 to 3.8 × 108 NPs/ml, mode par-
ticle sizes of 88–100 nm and average particle size of 120–169 nm.
Table 1
Analysis of plant extracts as well as biosynthesized zinc and silver nanoparticles by
inductively coupled plasma mass spectrometry (ICP-MS).
Plant
extracts/nanoparticles
Total concentration Zn
(mg/kg) mean ± SDa
Total concentration Ag
(mg/kg) mean ± SD
Leaf extract 1.4 ± 0.1 <0.005
Fruit extract 0.98 ± 0.14 <0.005
Zn-NPs-L 9.24 ± 0.54 n.d.b
Zn-NPs-F 25.6 ± 0.8 n.d.
Ag-NPs-L n.d. 2.1 ± 0.88 W.  Salem et al. / International Journal
embrane, 0.4 ml  HEPES buffer (10 mM,  pH 7.4) with 2% sarco-
yl was added and incubated at room temperature (RT) for 30 min.
fter centrifugation (15,600 × g, 30 min, 4 ◦C), the pellet contain-
ng the OMPs was  washed once with 0.5 ml  HEPES buffer (10 mM,
H 7.4) and ﬁnally re-suspended in 50 l HEPES buffer (10 mM,  pH
.4). Puriﬁed OMPs were stored at −20 ◦C.
The protein concentrations of OMP  preparations were deter-
ined by photometric measurements of the absorbances at
60 nm and 280 nm using a Beckman Coulter DU730 spec-
rophotometer in combination with a TrayCell (Hellma)
nd the Warburg–Christian equation given as mg  pro-
ein/ml = [(1.31 × A280) − (0.57 × A260)] × dilution factor
Warburg and Christian, 1941).
DS-PAGE and immunoblot analysis
To separate proteins the standard sodium dodecyl sulfate-
olyacrylamide gel electrophoresis (SDS-PAGE) procedure in
ombination with 15% gels and the Prestained Protein Marker Broad
ange (New England Biolabs) as a molecular mass standard was
sed (Laemmli, 1970). Approximately 5 g protein was loaded for
ach sample. Proteins were stained according to Kang et al. (Kang
t al., 2002) or transferred to a nitrocellulose membrane (Amer-
ham) for immunoblot analysis, which was essentially performed
s described previously (Roier et al., 2012), using anti-OmpU or
nti-OmpT antisera generated in mouse (1:500 diluted in 10%
kim milk) as primary and peroxidase-conjugated goat anti-mouse
diluted 1:10,000 in 10% skim milk, Dianova GmbH, Hamburg) as
econdary antibody, respectively.
urvival curve of V. cholerae and ETEC in the presence of Ag-NPs-L
For the time-dependent survival analysis, a bacterial overnight
ulture was diluted 1:10,000 using LB-Sm broth supplemented
ith aliquots of Ag-NPs-L (ﬁnal concentration of 2.4 × 107 or
.2 × 107 NPs/ml). Cultures were grown without agitation at 37 ◦C
using same conditions as for the MIC  assay described above),
nd 100 l were collected at the indicated time intervals, serially
iluted in LB-Sm sterile broth and plated onto LB-Sm agar plates.
iable colonies were counted after 16 h at 37 ◦C. According to the
olume plated on agar plates, the limit of detection for this assay
as 10 CFU/mL.
n vivo colonization assay
In vivo experiments were performed as previously described
ith some modifactions (Leitner et al., 2013; Moisi et al., 2009;
child et al., 2007). CD-1 mice (Charles River Laboratories) were
sed in all experiments in accordance with the rules of the ethics
ommittee at the University of Graz and the corresponding animal
rotocol, which has been approved by the Austrian Federal Ministry
f Science and Research Ref. II/10b. Mice were housed with food and
ater ad libitum and monitored under the care of full-time staff.
ice were separated from their dams 1 h before infection. Sub-
equently, they were anesthetized by inhalation of isoﬂurane gas
nd then inoculated by oral gavage with 50 l of V. cholerae or ETEC
approx. 1 × 105 CFU/mouse for both pathogens). To determine the
xact inputs appropriate dilutions of the inocula were plated on
B-Sm plates. 6 h post-infection, infected mice were divided into
wo groups. One group were treated orally with 50 l of Ag-NPs–L
1.2 × 108 NPs/ml), while the other group received 50 l saline solu-
ion. After 24 h, the mice were sacriﬁced and the small intestine
rom each mouse was collected by dissection. The small intes-
ine was mechanically homogenized in LB broth with 15% glycerol
nd appropriate 1:10 dilutions were plated on LB-Sm. After incu-
ation at 37 ◦C ON, the colonization rates in CFU/small intestinedical Microbiology 305 (2015) 85–95
were determined by back-calculation to the original volume of the
homogenized small intestine.
Statistical analysis
Data were analyzed using the Mann–Whitney U test or a
Kruskal–Wallis test followed by post hoc Dunn’s multiple compar-
isons. Differences were considered signiﬁcant at P values of ≤0.05.
For all statistical analyses, GraphPad Prism version 4.0a was used.
Results
Characterization of the nanoparticles
Zinc oxide and silver nanoparticles (ZnO-NPs and Ag-NPs) were
synthesized according to established protocols using leaf (L) and
fruit extracts (F) from C. procera (Geethalakshmi and Sarada, 2010;
Hui et al., 2004; Sangeetha et al., 2011; Song and Kim, 2009),
resulting in the four different types of nanoparticles ZnO-NPs-L,
ZnO-NPs-F, Ag-NPs-L and Ag-NPs-F. After the addition of leaf and
fruit extracts to the silver or zinc nitrate solutions, color changes
appeared within 30 min  indicating the completion of the reaction,
which is due to the excitation of plasmon vibrations in the metal
nanoparticles (data not shown). In contrast, the control silver or
zinc nitrate solution without extracts showed no color change (data
not shown). The intensity of colors steadily increased along the
incubation period. Finally, Ag-NPs-L and Ag-NPs-F solutions exhib-
ited a dark brown color, while solutions of Zn-NPs-L and Zn-NPs-F
exhibited dark yellow color. This may  be due to the excitation of the
surface plasmon resonance (SPR) effect (Haes and Van Duyne, 2002)
and the reduction of either AgNO3 (Mulvaney et al., 1996) or zinc
nitrate (Sangeetha et al., 2011). The reduction of aqueous extracts
by silver or zinc ions and the formation of each NP-type were con-
ﬁrmed using UV–vis spectroscopy (Fig. 1). A wavelength scans in
the UV–vis spectra revealed an absorption peak at approximately
 = 340 for ZnO-NPs-L and Zn-NPs-F (Fig. 1A and B). Furthermore
Ag-NPs-L and Ag-NPs-F exhibited characteristic absorption peaks
at approximately  = 370 nm as previously published (Jeeva et al.,
2014) (Fig. 1C and D). The presence of Zn and Ag in the NPs solutions
was conﬁrmed by inductively coupled plasma mass spectrometry
(ICP-MS), which revealed an at least 7-fold increase in case of Zn
or 400-fold in case of Ag in the NPs solutions compared to the
plant extracts, respectively (Table 1). The exact size distributions
and concentrations of independent NP preparations used in the
assays presented herein were determined by nanoparticle track-
ing analysis (Fig. 2). Throughout the study, each type of NP has
been prepared at least three times without tremendous changes inAg-NPs-F n.d. 10 ± 3
a Results are given as mean ± standard deviation of at least three independent
preparations.
b Not determined.
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Fig. 1. UV–vis spectra for the reaction mixture containing of nanoparticles (NPs) synthesized from C. procera leaves (L) and fruits (F). Shown are the UV–vis absorption spectra
from  220 to 800 nm of ZnO-NPs-L(A), ZnO-NPs-F (B), Ag-NPs-L (C) and Ag-NPs-F (D).
Fig. 2. Characterization of biosynthesized zinc and silver nanoparticles by nanopar-
ticles tracking analysis (NTA). Shown are the concentrations of NPs (A) as well as the
NP  sizes (B) presented as average (gray bars) and mode (white bars) NPs diameter
sizes in nm.  At least three independent preparations of each NP type were analyzed.
The data is presented as the mean ± standard deviation (SD).The difference between mode and average particle sizes indicates
a non-parametric distribution of the NPs with the majority ranging
around 90–100 nm in size as well as a minor population with bigger
diameters. No aggregations or debris were detected by visualiza-
tion of the NPs within the nanoparticle tracking analysis (data not
shown), which indicates that NP suspensions are quite pure and
homogenous.
Antimicrobial activity of ZnO-NPs and Ag-NPs against V. cholerae
and ETEC.
Antibacterial activity of the different NPs  synthesized by C. pro-
cera plant extracts against the human pathogens V. cholerae and
ETEC was analyzed by minimal inhibitory concentration (MIC) and
INT assays (Fig. 3). MIC  was deﬁned as the lowest concentration
at which no increase of the OD600 of the pathogens was  observed.
However, in the absence of cell lysis the measurement of turbidity
cannot distinguish between live and dead bacteria (Carroll et al.,
2010). Thus, we additionally determined bacterial viability by a
colorimetric INT-formazan assay, which allows detection of viable
bacteria by their respiratory activity (Mann and Markham, 1998;
Palomino et al., 2002). All four NPs showed reproducible, effective
antibacterial activity with similar results in both assays (Fig. 3).
In general, ZnO-NPs showed a slightly higher efﬁcacy compared
to Ag-NPs, with ZnO-NPs-F exhibiting the lowest MIC  against both
pathogens. In detail, ZnO-NPs concentrations of 1.6 × 105–1.2 × 106
per ml  were sufﬁcient for killing of V. cholerae and ETEC (Fig. 3A and
B), while in case of the Ag-NPs concentration of 5 × 106–1.2 × 107
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Fig. 3. Antibacterial activity of ZnO-Nps and Ag-Nps against V. cholerae and ETEC. Minimal inhibitory concentrations (MIC) for growth (gray bars) and metabolic activity
(open  bars) against V. cholerae and ETEC were determined for ZnO-NPs-L (A), ZnO-NPs-F (B), Ag-NPs-L (C) and Ag-NPs-F (D). MIC  for growth was  determined by measuring
OD600 measurement and MIC for metabolic activity was  assessed by a tetrazolium reduction assay. Please refer to the materials and methods section for details. Shown are
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er ml  were necessary (Fig. 3C and D). Within the MIC  and INT
ssays no detectable difference compared to the LB control were
bserved in the presence of plant extracts alone (data not shown).
onsistently, a comprehensive analysis revealed that neither the
resence of leaf nor fruit extracts had a negative effect on the
rowth kinetics or viability of V. cholerae or ETEC in comparison
o the LB control (Fig. 4). To exclude the possibility of soluble
ide-products with antimicrobial activity in the NPs solution, the
Ps-free supernatants from NPs solutions were obtained by cen-
rifugation and tested in the MIC/INT assay. The absence of NPs
n the supernatant was conﬁrmed by NTA. None of the NP-free
upernatants derived from the four types of NPs solutions (ZnO-
Ps-L, ZnO-NPs-F, Ag-NPs-L and Ag-NPs-F) exhibited any residual
ntimicrobial activity. Thus, the determined MIC correlates with
he presence of NPs.
nO-NPs and Ag-NPs have inverse effects on bioﬁlm formation
Bioﬁlm formation is an important survival strategy and persis-
ence mode between epidemic outbreaks of the facultative human
athogens V. cholerae and ETEC (Ahmed et al., 2013; Colwell et al.,
003). Recent ﬁndings suggest, that bioﬁlms are a likely form in
hich V. cholerae and ETEC are taken up by humans, providing
 concentrated infective dose (Ahmed et al., 2013; Colwell et al.,
003; Hall-Stoodley and Stoodley, 2005; Huo et al., 1996; Seper
t al., 2011; Tamayo et al., 2010). Since bioﬁlms are generally known
o promote resistance against several antimicrobial agents (Lewis,
005, 2008), we analyzed the impact of NPs on V. cholerae or ETEC
ioﬁlms. Therefore, we allowed V. cholerae or ETEC to form static
ioﬁlms for 24 h before ZnO-NPs-L, ZnO-NPs-F, Ag-NPs-L or Ag-
Ps-F were added. Addition of LB broth, C. procera fruit or leaf
xtract served as controls, respectively. Finally, after an additional
ncubation period of 24 h the bioﬁlm amount was quantiﬁed by
rystal violet staining (Fig. 5). Addition of plant extract (fruit or leaf)
ad either no or a beneﬁcial effect on bioﬁlm formation in compari-
on to the LB control. Thus, the NPs treated bioﬁlms were compared
ith the appropriate fruit or leaf plant extract, respectively. Addi-
ion of Ag-NPs-F showed no change in bioﬁlm formation of both
athogens (Fig. 5A and B). In case of ETEC, treatment with ZnO-
Ps-L, ZnO-NPs-F and Ag-NPs-L signiﬁcantly reduced the bioﬁlm
mount compared to the plant extract treated control, respectively
Fig. 5B). This could also be observed for Ag-NPs-L treated bioﬁlms
f V. cholerae (Fig. 5A). In contrast, treatment with ZnO-NPs-L and
nO-NPs-F had an opposite effect and signiﬁcantly increased the
ioﬁlm amount of V. cholerae.nterquartile range.
The pronounced increase in bioﬁlm formation of V. cholerae
treated with ZnO-NPs was  unexpected. However, it was recently
shown that adenylyl cyclases can be inhibited by Zn and conse-
quently a sublethal concentration of ZnO-NPs could decrease cAMP
levels in V. cholerae (Klein et al., 2002, 2004). Besides others, the
second messenger cAMP negatively effects bioﬁlm formation as
well as expression of the cholera toxin and the major coloniza-
tion factor TCP in V. cholerae (Fong and Yildiz, 2008; Skorupski and
Taylor, 1997a, 1997b). Thus, treatment with sublethal concentra-
tions of ZnO-NPs could cause adverse effects and induce bioﬁlm
formation and virulence. Interestingly, the outer membrane porin
OmpT is positively regulated by this second messenger and lack
of cAMP completely abolishes OmpT expression (Li et al., 2002).
In order to conﬁrm the hypothesis of adenylyl cyclase inhibition
by ZnO-NPs, the outer membrane (OM) proteins were isolated
from V. cholerae cultures grown in absence or presence of sub-
lethal concentrations of ZnO-NPs, Ag-NPs or zinc- and silver nitrate
solutions. Subsequently, these OM preparations were subjected to
immunoblot analysis (Fig. 6). Kang staining and detection of OmpU
by immunoblot served as loading controls (Fig. 6A and C). While no
difference in the abundance of OmpU was observed, all prepara-
tions grown in presence of ZnO-NPs or zinc nitrate exhibited only
low levels of OmpT (Fig. 6B, lane 2, 3, 4). This result strengthens
the hypothesis that treatment with ZnO-NPs inhibits the adenylyl
cyclase activity resulting in low cAMP levels.
Ag-NPs-L kills V. cholerae faster than ETEC
Based on these results ZnO-NPs may  interfere in cAMP signaling
and cause adverse effects. In addition, Ag-NPs-F had no impact on
bioﬁlm formation of both pathogens. Thus, Ag-NPs-L were selected
for further analysis. First, the killing dynamic of Ag-NPs-L against
log-phase cultures of V. cholerae and ETEC was determined (Fig. 7).
Two different concentrations of Ag-NPs-L were tested, with one
close to the MIC  and the other 2-fold higher. Addition of Ag-NPs-L at
these two  different concentrations to a V. cholerae culture resulted
in both cases in a rapid, continuous drop of viable cells with no
detectable CFUs after 2 h (Fig. 7A). In the case of ETEC, killing was
delayed with a steady decrease of CFUs over time for both concen-
trations tested. Finally no detection of viable cells could be observed
after 20 h for the higher or 22 h for the lower concentration of Ag-
NPs-L, respectively (Fig. 7B). Based on these results, Ag-NPs-L kill V.
cholerae faster than ETEC. Furthermore, concentrations above the
MIC  do not shorten the duration of killing.
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Fig. 4. C. procera plant extracts do not affect growth or viability of V. cholerae and
ETEC. Shown are the growth kinetics of V. cholerae (A) and ETEC (B) in LB broth
with leaf (dashed line) or fruit extracts (dotted line). LB broth alone served as con-
trol  condition (solid line). Shown are the medians from at least six independent
measurements. (C) At 24 h the CFU/ml was determined by plating appropriate dilu-
tions on LB plates. Data represent mean ± standard deviation (SD) of at least three
independent measurements.
Fig. 5. Impact of NPs on bioﬁlms of V. cholerae and ETEC. V. cholerae (A) and ETEC
(B)  bioﬁlms were allowed to grow for 24 h before ZnO-NPs-L, ZnO-NPs-F, Ag-NPs-L
or  Ag-NPs-F were added. Addition of LB broth (LB), plant extracts from leaves (PE-L)
or  fruits (PE-F) served as a control. After an additional 24 h bioﬁlm formation was
quantiﬁed by crystal violet staining and subsequent determination of the OD595.
Shown are the medians from at least eight independent measurements. The error
bars indicate the interquartile range. Signiﬁcant differences between the data sets
are marked by asterisks (P < 0.05; Kruskal–Wallis test and post hoc Dunn’s multiple
comparisons).
Fig. 6. Immunoblot analysis of outer membrane preparations derived from V.
cholerae treated with NPs. Depicted are the immunoblots for the detection of OmpU
(A)  or OmpT (B) as well as the protein proﬁles after Kang-staining (C) of OM
preparations from V. cholerae grown in LB broth without supplements (lane 1) or
supplemented with zinc nitrate (lane 2), ZnO-NPs-L (lane 3), ZnO-NPs-F (lane 4), Ag-
NPs-L (lane 5), Ag-NPs-F (lane 6), C. procera leaf extract (lane 7) or C. procera fruit
extract (lane 8). Samples (approx. 6 g protein each) were separated by SDS-PAGE
(15% gels) and protein bands were visualized according to Kang et al. (2002). Lines
to  the left indicate the molecular masses of the protein standards in kDa.
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Fig. 7. Survival curve of V. cholerae and ETEC in presence of Ag-NPs-L. Shown are the
median CFU of V. cholerae (A) and ETEC (B) in LB broth supplemented with 2.4 × 107
Ag-NPs-L/ml (solid line) or 1.2 × 107 Ag-NPs-L/ml (dashed line) over time. Shown are
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Fig. 8. Impact of Ag-NPs-L on colonization ﬁtness of V. cholerae and ETEC. Shown
are  the recovered CFU per small intestine from mice orally infected with either V.
cholerae (A) or ETEC (B). 6 day old CD-1 mice were inoculated with either V. cholerae
or  ETEC (approx. 1.5 × 106 CFU per mouse for both pathogens). At 6 h post infection
the control group (co) received 50 l saline while treatment group received 50 l Ag-
NPs-L solution (1.2 × 108 NPs/ml). At 24 h post infection, the small intestines were
collected, homogenized in LB medium and plated for CFU counting. Each column
represents the recovered CFU per small intestine from at least eight mice. The hori-
zontal bars indicate the median of each data set. Signiﬁcant differences between thehe medians from at least three independent measurements. The error bars indicate
he interquartile range of each data set for each time point. The limit of detection
or  this assay was  10 CFU.
ral treatment with Ag-NPS-L reduces colonization of V. cholerae
nd ETEC.
Finally, we addressed the impact of Ag-NPs-L on the small intes-
ine colonization of V. cholerae or ETEC using the infant mouse
odel. Therefore, mice were infected with V. cholerae or ETEC and
rally treated with an Ag-NPs-L solution 6 h post-infection. The
ontrol group received an equal volume of saline buffer, which was
lso administered orally. The number of V. cholerae CFU recovered
rom the small bowel at 24 h post-infection are shown in Fig. 8. All
ontrol mice were stable colonized with median colonization lev-
ls of 3 × 105 for V. cholerae or 5 × 104 CFU for ETEC, respectively.
reatment with Ag-NPs-L resulted in a signiﬁcant decrease in the
olonization levels, with a 50-fold reduction in case of V. cholerae
nd 200-fold reduction for ETEC compared to the control groups.
iscussion
Several approaches have been employed to improve the meth-
ds for synthesizing Ag- and ZnO-NPs including chemical and
iological methods. Recently, nanoparticles synthesis based on
lant extracts is becoming more popular (Abasaheb et al., 2013;
uzan et al., 2014; Vimala et al., 2014). For example, Ag-NPs were
repared from Aloe vera extract after 24 h of incubation or from
calypha indica leaf extract after only 30 min  of incubation using
queous solutions of silver nitrate (Chandran et al., 2006; Krishnaraj
t al., 2010). In the current study, Ag- and ZnO-NPs were rapidlydata sets are marked by asterisks (P < 0.05; Kruskal–Wallis test and post hoc Dunn’s
multiple comparisons).
synthesized from leaf and fruit extracts of C. procera within 2 h
of incubation. The main mechanism is based on a plant-assisted
reduction due to C. procera phytochemicals including ﬂavones,
organic acids, and quinones that are water soluble and are respon-
sible for the immediate reduction of the ions (Iravani, 2011; Jha
et al., 2009; Prabhu and Poulose, 2012). The formation of polydis-
persed nanoparticles with concentrations of approx. 108 NPs/ml in
the aqueous solution was conﬁrmed by UV–vis spectrometry and
NTA analysis. The obtained yield, particle size and general quality
is consistent with recent reports using aqueous extracts of neem
and triphala leaves for synthesis of Ag-NPs or ZnO-NPs (Chandran
et al., 2006; Ponarulselvam et al., 2012) (Asmita et al., 2012; Prabhu
and Poulose, 2012; Sangeetha et al., 2011; Suzan et al., 2014; Vimala
et al., 2014). It was also concluded that nanoparticle solutions were
stable for more than six months with little signs of aggregation
(Ankanna et al., 2010; Ponarulselvam et al., 2012; Saifuddin et al.,
2009).
The antibacterial activities of phyto-synthesized Ag-NPs and
ZnO-NPs were studied against the two Gram-negative pathogens V.
cholerae and ETEC, which are dominant bacterial causative agents
for diarrheal diseases. Although both NPs exhibited robust antibac-
terial activity in the MIC  and INT assays, the ZnO-NPs generally
showed a slightly higher efﬁcacy against both pathogens com-
pared to Ag-NPs. Interestingly, the amount of NPs necessary for
growth inhibition (MIC assay) and inhibition of metabolic activ-
ity (INT assay) was almost equal, suggesting that the dominant
antimicrobial target of the NPs are metabolic pathways of the bacte-
ria. Noteworthy, antibiotic resistance of bacterial bioﬁlms may  be
caused by poor antibiotic penetration within the bioﬁlm matrix, an
altered microenvironment or an adaptive bacterial response. Such
mechanisms acting together can raise the antibiotic resistance of
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ioﬁlms by up to 1000 times in comparison with free living bacte-
ial cells (Mah  and O’Toole, 2001). The aforementioned attributes
f bioﬁlms place them amongst the most serious problems, which
edicine is currently facing. Thus, considerable effort has been
ade to identify novel technologies that could form the basis of
nti-bioﬁlm therapies, which are superior to current antibiotic
reatment strategies. As a potential application for water disinfec-
ion the NPs should also affect bioﬁlms of these pathogens.
Interestingly, addition of ZnO-NPs to V. cholerae enhanced
ioﬁlm formation. A possible explanation might be the inhibi-
ion of the adenylyl cyclase by Zn-based compounds (Klein et al.,
002, 2004). Consequently, cAMP levels are decreased, which de-
epresses bioﬁlm formation in V. cholerae. Consistent with this
ypothesis we found only low levels of the cAMP-induced porin
mpT in the OM of V. cholerae treated with sublethal concen-
rations of ZnO-NPs. Noteworthy, the second messenger cAMP is
nvolved in multiple regulatory pathways in V. cholerae including
atural competence, chitin colonization, outer membrane compo-
ition, motility, bioﬁlm formation and virulence gene expression
Antonova et al., 2012; Blokesch, 2012; Liang et al., 2007; Nielsen
t al., 2010). Although in most cases the exact mechanisms are
ot yet fully understood, it was reported earlier that cAMP nega-
ively affects bioﬁlm formation as well as expression of the cholera
oxin and the major colonization factor TCP (Fong and Yildiz, 2008;
korupski and Taylor, 1997a, 1997b). Since, ZnO-NPs treatment
ight cause adverse effects by unleashing bioﬁlm formation or
irulence; we  did not pursue other studies on ZnO-NPs.
In contrast to ZnO-NPs, treatment with Ag-NPs-L signiﬁcantly
educed bioﬁlms of ETEC and V. cholerae. Consistent with our
esults, Ag-NPs have been recently shown to inhibit and reduce
ioﬁlm formations of several bacterial species (Markowska et al.,
013). For example, studies in rabbits showed that nanoparticle
ilver ion-coated implants inhibited Staphylococcus aureus bioﬁlm
ormation without causing silver accumulation in host tissues, even
8 d after impregnation (Gupta et al., 2014; Kalishwaralal et al.,
010; Markowska et al., 2013; Secinti et al., 2011).
Besides ex vivo application for bioﬁlm reduction and water
isinfection, we also demonstrated that oral administration of Ag-
Ps-L can lower the colonization levels of V. cholerae and ETEC
n vivo. Gastrointestinal intake of NPs may  indeed occur through
ano-technological food, packaging or medical applications. Still,
nhalation accounts for the majority of NPs exposure routes in
umans, as NPs can be released into air in occupational settings
Klien and Godnic-Cvar, 2012). Consistent with other reports, we
bserved no adverse side effects by single oral administration of Ag-
Ps, which suggests that the colloidal Ag-NPs-L had no acute toxic
ffects (Quang et al., 2013). For example, Pattwat and coworkers
eported that the colloidal Ag-NPs was found to be nontoxic when
ral, ocular and dermal toxicity tests in mice and guinea pigs were
erformed (Pattwat et al., 2011). The repeated-dose toxicity was
ssayed in rats and mice given Ag-NPs for 28-days (Eun-Jung et al.,
010; Kim et al., 2008). While no signiﬁcant changes in body weight
ould be observed, exposure to high doses of more than Ag-NPs
300 mg/kg for rats and 1 mg/kg in mice) resulted in adverse effects
ndicating slight liver or kidney damages. In general, the accumu-
ation in tissues seems to occur in a dose-dependent manner only
fter repeated treatment (Quang et al., 2013).
This study provides a ﬁrst characterization of the potential appli-
ations of nanoparticles as antibacterial therapeutic agents against
. cholerae and ETEC. Based on our results Ag-NPs offer an inex-
ensive alternative approach to reduce the infectious dose of the
athogens in contaminated water and might also be applicable for
n vivo therapy of diarrheal diseases. However, further in vitro and
olecular studies are needed to elucidate the clear evidence of
oxic mechanisms that will be related to Ag+. Further long-term
oxicity, mutagenicity and carcinogenicity studies are required todical Microbiology 305 (2015) 85–95 93
clarify any adverse effects and are necessary to support the safe use
of colloidal Ag-NPs. The fast and simple synthesis of nanoparticles
does not require special trained staff or expensive equipment and
is likely to be performed in epidemic areas. In contrast to antibi-
otics, prolonged exposure of bacteria to silver nanoparticles has not
resulted in the development of resistant cells so far. Silver nanopar-
ticles as biocides tend to target multiple sites on or within bacterial
cells and hence have a broad spectrum activity (Markowska et al.,
2013). Thus, the application of silver nanoparticles as an effec-
tive antimicrobial agent should not cause microbial resistance even
after long-term usage.
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